A carregar...

Treatment of Pancreatic Cancer with Pharmacological Ascorbate

The prognosis for patients diagnosed with pancreatic cancer remains dismal, with less than 3% survival at 5 years. Recent studies have demonstrated that high-dose, intravenous pharmacological ascorbate (ascorbic acid, vitamin C) induces cytotoxicity and oxidative stress selectively in pancreatic can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Pharm Biotechnol
Main Authors: Cieslak, John A., Cullen, Joseph J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4895694/
https://ncbi.nlm.nih.gov/pubmed/26201606
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!